Skip to Main Content

Paper Details

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
Ann Oncol
249
2018
Author NameAffiliation
Alejandra BrunaCancer Research UK Cambridge Institute, University of Cambridge
Oscar M RuedaCancer Research UK Cambridge Institute, University of Cambridge
Zhongwu Lai
William J HowatCancer Research UK Cambridge Institute
William J HowatCancer Research UK Cambridge Institute
Isabel T RubioBreast Cancer Center, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona
J. Carl Barrett
Carlos CaldasDepartment of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust
José BaselgaMemorial Sloan Kettering Cancer Center
Jos Jonkers
  • 1 - 10

Datasets